肝细胞癌
医学
突变
癌症研究
桑格测序
生物
基因
遗传学
作者
Rongqi Sun,Kaixuan Liu,Si-Yuan Pan,Yuhang Ye,Ning Li,Shuangyi Chen,Xinyi Cui,Yuxi Zhang,Long Chen,Jingyue Pan,Zhiqiang Hu,Chu‐Bin Luo,Jia Fan,Zheng‐Jun Zhou,Shao‐Lai Zhou,Jian Zhou
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2024-12-24
卷期号:82 (5): 1073-1089
被引量:4
标识
DOI:10.1097/hep.0000000000001212
摘要
Our results identified novel LRP4 mutations important in recurrent HCC. Inactivating LRP4 mutations were associated with resistance to anti-programmed cell death protein-1 therapy and could be useful biomarkers for precision therapy in patients with recurrent HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI